J.P. Morgan - New York City Jul 2012 - Dec 2012
Intern---IB
Consulting Club at Virginia Tech - Blacksburg,VA Jan 2011 - Dec 2011
Treasurer
China GF Securities Ltd. - Guangzhou, China Jul 2011 - Aug 2011
Intern
California State University, Chico - Chico,CA Feb 2010 - May 2010
Teaching Assistant
Lulu's Fashion Lounge - CHICO,CA Mar 2009 - Jul 2009
Intern
Education:
Virginia Polytechnic Institute and State University 2010 - 2012
Master of Accounting and Information System, Audit
CSU Chico 2008 - 2010
MBA, Business Administration
Honor & Awards:
California State University, Chico
• MBA Academic Excellence Award
• Dean’s Honor List for Fall 2008 and Spring 2009
New York Police Department New York, NY Feb 2011 to May 2011 Desk Appearance Ticket Office InternAmeriCorp New York, NY Jan 2010 to Dec 2010 Community and Volunteer Mobilization AmeriCorpsLaw Office of Raymond Lo New York, NY May 2010 to Nov 2010 Legal Assistant / ParalegalEast Met West Chinese Restaurant Brooklyn, NY May 2008 to Aug 2008 Restaurant Cashier
Education:
Pace University, Dyson College of Arts & Sciences New York, NY May 2012 Bachelor of Science in Criminal JusticeLingnan University Hong Kong, Hong Kong Island 2011 to 2011 Study Abroad
Skills:
Chinese (Mandarin)
Name / Title
Company / Classification
Phones & Addresses
Meng Hong Chen Chairman of the Board
FIFTH AVENUE INC Department Store
343 5 Ave, New York, NY 10003 85-48 148 St, Jamaica, NY 11435
Meng X. Chen Chairman
OSCAR NAILS & SPA II INC Physical Fitness Facility
33-17 Francis Lewis Blvd, Flushing, NY 11358 3317 Francis Lewis Blvd, Flushing, NY 11358
Meng Chen
MEMORIES OF FIFTH AVENUE INC
381 5 Ave, New York, NY 10016
Meng Dong Chen
NEW YORK LOOK BOUTIQUE INC
840 8 Ave, New York, NY 10019
Meng Hong Chen
SOUVENIR DEPOT, INC
381 5 Ave, New York, NY 10006 85-48 148 St, Jamaica, NY 11435
Us Patents
Ophthalmic Compositions For Treating Ocular Hypertension
Meng Hsin Chen - Westfield NJ, US James B. Doherty - Montvale NJ, US Luping Liu - Plainsboro NJ, US Swaminathan Natarajan - Scotch Plains NJ, US Robert M. Tynebor - Woodbridge NJ, US
This invention relates to potent potassium channel blocker compounds of Formula (I) or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans, or a pharmaceutically acceptable salt, in vivo hydrolysable ester, enantiomer, diastereomer or mixture thereof: formula (II) represents Caryl or Cheterocyclyl, said aryl or heterocyclyl optionally substituted with 1-3 groups selected from R; Z represents (CH)PO(OR)(OR*).
Ophthalmic Compositions For Treating Ocular Hypertension
Meng Hsin Chen - Westfield NJ, US James B. Doherty - Montvale NJ, US Luping Liu - Plainsboro NJ, US Swaminathan Natarajan - Scotch Plains NJ, US Robert M. Tynebor - Woodbridge NJ, US
This invention relates to potent potassium channel blocker compounds of structural Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.
Ophthalmic Compositions For Treating Ocular Hypertension
Meng Hsin Chen - Westfield NJ, US Luping Liu - Palainsboro NJ, US Peter Meinke - Plainfield NJ, US Ravi Natarajan - Scotch Plains NJ, US William Parsons - Belle Mead NJ, US Min Shu - Green Brook NJ, US John Stelmach - Westfield NJ, US Harold Wood - Westfield NJ, US Fengqi Zhang - Edison NJ, US David Wisnoski - Lansdale PA, US James Doherty - Montvale NJ, US
This invention relates to the use of potent potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.
Opthalmic Compositions For Treating Ocular Hypertension
Meng Hsin Chen - Westfield NJ, US James Doherty - Montvale NJ, US Luping Liu - Plainsboro NJ, US Swaminathan Natarajan - Scotch Plains NJ, US Min Shu - Greenbrook NJ, US
This invention relates to the use of potent potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.
The present invention comprises a process for the hydroxyalkylation of cardanol with cyclic organic carbonates in the presence of organic or inorganic catalysts and a novel composition of matter produced by that process. The unique molecular structure of cardanol allows the use of a variety of organic or inorganic basic catalysts, including triethylamine, imidazol, sodium hydroxide and sodium carbonate, in the hydroxyalkylation reaction without forming quantities of undesirable side-products. According to this invention, the final product, monohydroxyalkylcardanyl ether, can be obtained with high yield and high purity. The product has a light color and its color stability is enhanced by replacing the phenol's hydroxyl group with a more stable hydroxyalkoxyl group.
Meng H. Chen - Westfield NJ Zhijian Lu - Scotch Plains NJ Ravi Nargund - East Brunswick NJ Arthur A. Patchett - Westfield NJ James R. Tata - Westfield NJ Lihu Yang - Edison NJ Mu Tsu Wu - Clark NJ
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D20904 C07D21100 A61K 31445
US Classification:
514278
Abstract:
The present invention is directed to certain piperidines, pyrrolidines, and hexahydro-1H-azepines of the general structural formula: ##STR1## wherein B is selected from: ##STR2## and R. sup. 1, R. sup. 1a, R. sup. 2a, R. sup. 3a, R. sup. 3b, R. sup. 4, R. sup. 4a, R. sup. 4b, R. sup. 4c, R. sup. 5, D, X, Y, n, x and y are as defined herein. These compounds promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion, such as short stature in growth hormone deficient children, and to treat medical conditions which are improved by the anabolic effects of growth hormone. Growth hormone releasing compositions containing such compounds as the active ingredient thereof are also disclosed.
Naphthyl Compounds Promote Release Of Growth Hormone
Meng Hsin Chen - Westfield NJ Gregori J. Morriello - Belleville NJ Ravi Nargund - East Brunswick NJ Arthur A. Patchett - Westfield NJ Lihu Yang - Edison NJ
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31165 C07C23722
US Classification:
514616
Abstract:
The present invention is directed to certain compounds of the general structural formula: ##STR1## wherein R. sub. 1, R. sub. 1a, R. sub. 2a, R. sub. 3, R. sub. 3a, R. sub. 4, R. sub. 5, R. sub. 6, A, W, and n are as defined herein. These compounds promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion, such as short stature in growth hormone deficient children, and to treat medical conditions which are improved by the anabolic effects of growth hormone. Growth hormone releasing compositions containing such compounds as the active ingredient thereof are also disclosed.
Piperidines, Pyrrolidines And Hexahydro-1H-Azepines Promote Release Of Growth Hormone
Prasun K. Chakravarty - Edison NJ Meng H. Chen - Westfield NJ Ravi Nargund - East Brunswick NJ Arthur A. Patchett - Westfield NJ James R. Tata - Westfield NJ Mu Tsu Wu - Clark NJ Lihu Yang - Edison NJ
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A01N 4354 C07D41300 C07D21500 C07D45302
US Classification:
5142278
Abstract:
The present invention is directed to certain piperidines, pyrrolidines, and hexahydro-1H-azepines of the general structural formula: ##STR1## wherein B is selected from: ##STR2## and R. sup. 1, R. sup. 1a, R. sup. 2a, R. sup. 3a, R. sup. 3b, R. sup. 4, R. sup. 4a, R. sup. 4b, R. sup. 4c, R. sup. 5, D, X, Y, n, x and y are as defined herein. These compounds promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion, such as short stature in growth hormone deficient children, and to treat medical conditions which are improved by the anabolic effects of growth hormone. Growth hormone releasing compositions containing such compounds as the active ingredient thereof are also disclosed.
License Records
Meng Chen
Address:
New York, NY 10022
License #:
1545
Issued Date:
Nov 26, 2012
Type:
Real Estate Appraiser Temporary Permit
Googleplus
Meng Chen
Work:
CBI
Education:
Shanghai International Studies University
Meng Chen
Education:
Massachusetts College of Art - Fashion Design
Tagline:
Fashion graduate student from Massachusetts College of Art and Design